Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Pharmacy / Generic drug / Pfizer / Takeda Pharmaceutical Company / Bristol-Myers Squibb / Pharmaceutical drug / Eisai / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy


Japan Industry Outlook[removed]No.1 Table of Contents 1, Comprehensive Industry - Japan 2, Iron and Steel - Japan
Add to Reading List

Document Date: 2013-03-27 06:30:22

Open Document

File Size: 265,24 KB

Share Result on Facebook

City

Bristol / /

Company

Eli Lilly / Takeda Pharmaceutical / Nycomed / S hionogi & Co. Company / Novartis / Otsuka Holdings Co. Ltd. / Mitsubishi Tanabe Pharma Corporation / Dainippon Sumitomo Pharma / Mizuho Corporate Bank / Eisai Inc. / Ranbaxy / Pfizer / GlaxoSmithKline / Merck / IMS Health / Daiichi Sankyo / Shionogi & Co. / Astra / Takeda Pharmaceutical Company / Chugai Pharmaceutical / U.S. net / Astellas Pharma / Materials Team Industry Research Division Mizuho Corporate Bank Ltd. / Marine Shipping / /

Continent

Europe / /

Country

Germany / Italy / France / Japan / United States / United Kingdom / China / Spain / India / /

Currency

USD / EUR / JPY / /

/

Event

M&A / Patent Issuance / /

IndustryTerm

drug makers / pharmaceutical industry / drug technology / drug discovery technologies / pharmaceutical / pharmaceutical medium / pharmaceuticals / drug manufacturers / treatment of intractable diseases / pharmaceutical market / /

MedicalCondition

intractable diseases / Illness / cancer / disease / Outlook (Pharmaceuticals) cancer / Cancer Cancer / chronic disease / diseases / /

Organization

Ministry of Finance / Ministry of Health / /

Person

Takayuki Totsuka / Kenji Aoki / /

/

Position

driver / General / Major / /

Product

Prevacid / Cymbalta / Lipitor / Actos / Outlook / Seroquel / Plavix / Prograf / Singulair / Aricept / Zyprexa / /

Technology

drug technology / drug discovery technologies / drug discovery / drug development / Regenerative medicine / /

SocialTag